Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
Neuro65/AOCN2024
May 29 - Jun 1, 2024Tokyo International Forum
[HT-02-2]Development of tau-directed therapies for progressive supranuclear palsy
Yasuo Toda(Japan Clinical Development and Pharmacology, Biogen Japan Ltd., Japan)
1998: Graduated from Keio University School of Medicine
2004: Completed neurosurgical residency at Keio University and its affiliate hospitals
2005: Staff Neurosurgeon, Hiratsuka City Hospital (2006 - Neurosurgeon-in Chief)
2008: Senior Staff Neurosurgeon, Saiseikai Utsunomiya Hospital
2009: Clinical Research Center, Eisai Co., Ltd.
2010: Clinical Research Physician, Bristol-Myers K.K.
2014: CNS Senior Medical Advisor, Medical Affairs, MSD K.K.
2017: Associate Medical Director, Biogen Japan Ltd.
2021: Head of Japan Clinical Development and Pharmacology, Biogen Japan Ltd.
Password required to view
Abstract password authentication.
You can find the password on page 15 of the program book.
You can find the password on page 15 of the program book.